Mark has over 18 years of experience within the healthcare & pharmaceutical industry with startup and mid cap pharmaceutical companies being his expertise. Mark’s focus is to lead, grow, and develop Juno’s business functions, portfolio, customer base and team into the next phase of the Juno Canada story. 

Prior to being named President & CEO of Juno Pharmaceuticals Canada, Mark held the positions of Vice President, Sales & Marketing, North America and General Manager, Canada at Teligent Pharmaceuticals. 

Mark has also held senior positions at Mint Pharmaceuticals, Mylan and Genpharm. In addition, Mark has deep roots in growing organizations both in Canada and the USA who manufacture and market multiple dosage forms including prescription liquids, gels, ointments, ophthalmic, oral dose, and injectable products. Mark is well versed within the retail pharmacy, hospital, specialty, and animal health segments.